Neurol. praxi. 2016;17(6):370-372 | DOI: 10.36290/neu.2016.078

Primary lateral sclerosis

doc MUDr. Edvard Ehler, CSc.
Neurologická klinika Pardubická krajská nemocnice a Fakulta zdravotnických studií Univerzity Pardubice

Primary lateral sclerosis is a degenerative disease characterized by loss of motoneurons in precentral cortical region. Progressive spastic paresis with maximum of lower extremities, then of bulbar region, trunk and lesser of upper extremities is the most common clinical sydrome. A difficult spastic gait, dysarthria and dysphagia are characteristic symptoms. Differential diagnosis is very important, especially against amyotrophic lateral sclerosis, which has substantially worse prognosis. Decrease of spasticity, influence of dysphagia, dysarthria, and rehabilitation are the most important therapeutic measures of these severly affected patients.

Keywords: primary lateral sclerosis, spastic paraparesis, dysarthria, dysphagia, motor evoked potentials, EMG

Published: December 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ehler E. Primary lateral sclerosis. Neurol. praxi. 2016;17(6):370-372. doi: 10.36290/neu.2016.078.
Download citation

References

  1. Almeida V, Carvalho M, Scotto M, Pinto S, Pinto A, Ohana B, Swash M. Primary lateral sclerosis: Predicting funcional outcome. Amyotrophic Lateral Sclerosis and - Frontotemporal Degeneration 2013; 14: 141-145. Go to original source... Go to PubMed...
  2. Amato AA, Russell JA. Neuromuscular disorders. New York: McGraw Hill, 2008.
  3. Budrewicz S, Szewczyk P, Slotwinski K, Koszewicz M. Symptoms of degeneration of pyramidal tracts in conventional magnetic resonance imaging and diffusion tensor imaging in a young woman with a primary lateral sclerosis. J Postgrad Med 2015; 61: 203-208. Go to original source...
  4. Canu E, Agosta F, Galantucci S, Chio A, Riva N, Silani V, Falini A, Comi G, Fillipi M. Extramotor damage is associated with cognition in primary lateral sclerosis patients. PLOS ONE 2013; 8(12): 2017-2026. Go to original source...
  5. Floeter MK, Mills R. Progression in primary lateral sclerosis: a prospective analysis. Amyotrophic lateral sclerosis 2009; 10: 339-346. Go to original source... Go to PubMed...
  6. Fournier CN, Murphy A, Loci L, Mitsumoto H, Lomen-Hoerth C, Kisenuki Y, Simmons Z. Primary lateral sclerosis and early upper motor neuron disease: Characteristic of a cross - sectional population. J Clin Neuromusc Dis 2016; 17: 99-105. Go to original source... Go to PubMed...
  7. Iwata NK, Kwan JY, Danielian DE, Butman JA, Tovar-Mol F. Bayat E, Floeter MK. White matter alterations differ in primary lateral sclerosis and amyotrophic lateral sclerosis. Brain 2011; 134: 2642-2655. Go to original source... Go to PubMed...
  8. Kosaka T, Fu YJ, Shiga A, Ishidaira H, Tan CF, et al. Primary lateral sclerosis: Upper-motor-predominant amyotrophic lateral sclerosis with fronto-temporal lobar degeneration - immunohistochemical and biochemical analyses of TDP-43. Neuropathology 2012; 32: 373-384. Go to original source... Go to PubMed...
  9. Kuypers-Upmeijer J, de Jager AEJ, Hew JM, Snoek JW, van Weerden TW. Primary lateral sclerosis: clinical, neurophysiological, and magnetic resonance findings. J Neurol Neurosurg Psychiatry 2001; 71: 615-620. Go to original source... Go to PubMed...
  10. Le Forestier N, Maisonobe T, Piquard A, Rivaud S, Crevier-Buchman L, Salachas F, Pradat PF, Lacomblez L, Meininger V. Does primary lateral sclerosis exists? A study of 20 patients and a review of the literature. Brain 2001; 124: 1889-1899. Go to original source... Go to PubMed...
  11. Rektorová I. Frontotemporální lobární degenerace - diagnóza z neuropsychiatrického pomezí. Neurol. praxi 2006; 7(4): 208-211.
  12. Singer MA, Statland JM, Wolfe GI, Barohn RJ. Primary lateral sclerosis. Muscle Nerve 2007; 35(3): 291-302. Go to original source... Go to PubMed...
  13. Strong MJ, Gordon PH. Primary lateral sclerosis, spastic paraplegia and amyotrophic lateral sclerosis: Discrete entities or spectrum? Amyotrophic Lateral Sclerosis 2005; 6: 8-16. Go to original source... Go to PubMed...
  14. Turner MR, Hammers A, Al-Chalabi A, Shaw CE, Andersen PM, Brooks DJ. Cortical involvement of four cases of primary laateral sclerosis using [11C]-flumazenil PET. J Neurol 2007; 254(8): 1033-1036. Go to original source... Go to PubMed...
  15. Urban PP, Wellach I, Pohlmann C. Langsam progressive Dysarthrophonie bei primärer Lateralsclerose. Nervenarzt 2010; 81: 986-991. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.